S. Beslija: шукати на сайті Z-Library

Рік:

2001

Мова:

english

Файл:

PDF, 166 KB

english, 2001

Combined radio-chemotherapy (CR) in advanced cervical cancer: a phase-II trial with cisplatin and bleomycin

N. Kantardzic, S. Beslija, M. Musanovic, A. Cardzic, N. Kazic, N. Mahic, N. Paraganlija, J. Lomigoric, M. Banjin

Журнал:

Рік:

1999

Мова:

english

Файл:

PDF, 161 KB

english, 1999

165 Gemcitabine (G) plus carboplatin (C) in patients whose epithelial ovarian carcinomas (EOC) relapsed ≥ 6 months after platinum-containing first-line therapy: Preliminary results of a phase II study

F. Kose, J. Sufliarsky, S. Beslija, P. Saip, K. Krejcy, T. Minarik, E. Fitzthum, G. Tulunay, A. Melemed

Журнал:

Рік:

2003

Мова:

english

Файл:

PDF, 170 KB

english, 2003

Although higher expression of bcl-2 is associated with better outcome, bcl-2 is not an independent prognosticator of distant disease free survival (DDFS) or overall survival (OS) in breast cancer

S Hasanagic, S Vranic, S Beslija, I Selak, N Bilalovic

Журнал:

Рік:

2004

Мова:

english

Файл:

PDF, 162 KB

english, 2004

3046 POSTER A randomized, open-label phase II study evaluating the efficacy and safety of FOLFOX6 + Cetuximab versus FOLFIRI + Cetuximab as first-line therapy in patients with metastatic colorectal cancer

T.E. Ciuleanu, W. Scheithauer, G. Kurteva, J. Ocvirk, I. Koza, D. Papamichael, M. Wenczl, T. Brodowicz, C.C. Zielinski, S. Beslija

Журнал:

Рік:

2007

Мова:

english

Файл:

PDF, 55 KB

english, 2007

3068 POSTER Capecitabine + irinotecan + bevacizumab as first-line therapy for patients (pts) with metastatic colorectal cancer (MCRC): preliminary phase II study results

S. Beslija, M. Banjin, S. Jungic, N. Obralic, G. Kecman-Malcic, I. Rakita, B. Salkic, A. Pasic, L. Tinjic, E. Ajanovic

Журнал:

Рік:

2007

Мова:

english

Файл:

PDF, 80 KB

english, 2007

Safety results from a phase III study (TURANDOT trial by CECOG) of first-line bevacizumab in combination with capecitabine or paclitaxel for HER-2-negative locally recurrent or metastatic breast cancer

I. Lang, M.J. Inbar, Z. Kahán, R. Greil, S. Beslija, S.M. Stemmer, B. Kaufman, Z. Zvirbule, G.G. Steger, D. Messinger, T. Brodowicz, C. Zielinski

Журнал:

Рік:

2012

Мова:

english

Файл:

PDF, 302 KB

english, 2012

5058 Bevacizumab (Bev) combined with either capecitabine (X) or weekly paclitaxel (Pac) as first-line therapy for HER2-negative locally recurrent or metastatic breast cancer (LR/MBC): the CECOG phase III TURANDOT trial

I. Lang, M. Inbar, G. Steger, R. Greil, Z. Zvirbule, S. Beslija, Z. Kahán, V. Taskova, B. Kaufmann, C.C. Zielinski

Журнал:

Рік:

2009

Мова:

english

Файл:

PDF, 68 KB

english, 2009

G3 A phase III study comparing concurrent gemcitabine (Gem) plus cisplatin (Cis) and radiation followed by adjuvant Gem plus Cis versus concurrent Cis and radiation in patients with stage IIB to IVA carcinoma of the cervix

A. Dueñas-González, J.J. Zarba, J.C. Alcedo, P. Pattarunataporn, S. Beslija, F. Patel, L. Casanova, H. Barraclough, M. Orlando

Журнал:

Рік:

2009

Мова:

english

Файл:

PDF, 49 KB

english, 2009

Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer: interim efficacy results of the randomised, open-label, non-inferiority, phase 3 TURANDOT trial

Lang, Istvan, Brodowicz, Thomas, Ryvo, Larisa, Kahan, Zsuzsanna, Greil, Richard, Beslija, Semir, Stemmer, Salomon M, Kaufman, Bella, Zvirbule, Zanete, Steger, Günther G, Melichar, Bohuslav, Pienkowski

Журнал:

The Lancet Oncology

Рік:

2013

Мова:

english

Файл:

PDF, 420 KB

english, 2013

5053 POSTER Randomized Phase III Study of First-line Bevacizumab in Combination With Capecitabine or Paclitaxel for HER2-negative LR/MBC: Interim Safety Data

Inbar, M., Lang, I., Kahán, Z., Greil, R., Beslija, S., Stemmer, S.M., Kaufman, B., Zvirbule, Z., Steger, G.G., Zielinski, C.C.

Журнал:

British Journal of Cancer

Рік:

2011

Мова:

english

Файл:

PDF, 42 KB

english, 2011

Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses

Brodowicz, T, Lang, I, Kahan, Z, Greil, R, Beslija, S, Stemmer, S M, Kaufman, B, Petruzelka, L, Eniu, A, Anghel, R, Koynov, K, Vrbanec, D, Pienkowski, T, Melichar, B, Spanik, S, Ahlers, S, Messinger,

Журнал:

Рік:

2014

Мова:

english

Файл:

PDF, 195 KB

english, 2014

Second consensus on medical treatment of metastatic breast cancer

Beslija, S, Bonneterre, J, Burstein, H, Cocquyt, V, Gnant, M, Goodwin, P, Heinemann, V, Jassem, J, Kostler, W., Krainer, M, Menard, S, Petit, T, Petruzelka, L, Possinger, K, Schmid, P, Stadtmauer, E,

Журнал:

Рік:

2006

Мова:

english

Файл:

PDF, 117 KB

english, 2006

Third consensus on medical treatment of metastatic breast cancer

Beslija, S., Bonneterre, J., Burstein, H. J., Cocquyt, V., Gnant, M., Heinemann, V., Jassem, J., Kostler, W. J., Krainer, M., Menard, S., Petit, T., Petruzelka, L., Possinger, K., Schmid, P., Stadtmau

Журнал:

British Journal of Cancer

Рік:

2009

Мова:

english

Файл:

PDF, 149 KB

english, 2009

Predictive role of hand–foot syndrome in patients receiving first-line capecitabine plus bevacizumab for HER2-negative metastatic breast cancer

Zielinski, Christoph, Lang, Istvan, Beslija, Semir, Kahan, Zsuzsanna, Inbar, Moshe J, Stemmer, Salomon M, Anghel, Rodica, Vrbanec, Damir, Messinger, Diethelm, Brodowicz, Thomas

Журнал:

Рік:

2015

Мова:

english

Файл:

PDF, 264 KB

english, 2015

[IEEE 2014 IEEE International Power Modulator and High Voltage Conference (IPMHVC) - Santa Fe, NM, USA (2014.6.1-2014.6.5)] 2014 IEEE International Power Modulator and High Voltage Conference (IPMHVC) - New approach to breakdown voltage estimation after interruption of capacitive currents

Delie, Sead, Beslija, Dejan, Muratovic, Mahir, Kim, Myoung-Hoo, Kapetanovic, Mirsad, Zildzo, Hamid

Рік:

2014

Мова:

english

Файл:

PDF, 323 KB

english, 2014

[IEEE 2015 3rd International Conference on Electric Power Equipment – Switching Technology (ICEPE-ST) - Busan, South Korea (2015.10.25-2015.10.28)] 2015 3rd International Conference on Electric Power Equipment – Switching Technology (ICEPE-ST) - Capacitive current breaking capability estimation for a 145 kV 40 kA GIS circuit breaker

Delic, Sead, Beslija, Dejan, Gorenc, Dalibor, Hajdarovic, Armin, Kapetanovic, Mirsad

Рік:

2015

Мова:

english

Файл:

PDF, 884 KB

english, 2015

P-189 * Correlation between of expression of the enzyme topoisomerase I and p53 and result of irinotecan based therapy in patients with metastatic colorectal cancer

Pasic, A., Beslija, S., Djuran, A., Sefic-Pasic, I., Banjin, M., Ceric, T., Rasic, A., Hasanbegovic, B., Jalovcic, A., Kapisazovic, E.

Журнал:

Рік:

2015

Мова:

english

Файл:

PDF, 30 KB

english, 2015

1800 Final results for overall survival (OS), the primary endpoint of the CECOG TURANDOT prospective randomised trial evaluating bevacizumab-paclitaxel (BEV-PAC) vs BEV-capecitabine (CAP) for HER2-negative locally recurrent/metastatic breast cancer (LR/mBC)

Zielinski, C.C., Lang, I., Inbar, M., Kahan, Z., Greil, R., Beslija, S., Stemmer, S.M., Zvirbule, Z., Steger, G.G., Melichar, B., Pienkowski, T., Sirbu, D., Petruzelka, L., Eniu, A., Nisenbaum, B., Da

Журнал:

Рік:

2015

Мова:

english

Файл:

PDF, 74 KB

english, 2015

Breast cancer, locally advanced and metastatic

Zielinski, C., Lang, I., Inbar, M., Kahan, Z., Greil, R., Beslija, S., Stemmer, S. M., Kaufman, B., Zvirbule, Z., Steger, G., Melichar, B., Pienkowski, T., Sirbu, D., Petruzelka, L., Eniu, A., Nisenba

Журнал:

Рік:

2012

Мова:

english

Файл:

PDF, 419 KB

english, 2012

Long-term outcome of GIST patients treated with delayed imatinib therapy

Kurtovic-Kozaric, Amina, Kugic, Amina, Hasic, Azra, Beslija, Semir, Ceric, Timur, Pasic, Anes, Vranic, Semir, Kopric, Dijana, Iljazovic, Ermina, Todorovic Barbuscia, Jelena, Kozaric, Mirza, Ibisevic,

Журнал:

Batalovic, Mirza, Beslija, Dejan, Kapetanovic, Mirsad, Kim, Myoung-Hoo, Kim, Kyong-Hoe

Рік:

2017

Мова:

english

Файл:

PDF, 463 KB

english, 2017

[IEEE 2016 IEEE International Power Modulator and High Voltage Conference (IPMHVC) - San Francisco, CA, USA (2016.7.6-2016.7.9)] 2016 IEEE International Power Modulator and High Voltage Conference (IPMHVC) - Partial discharge measurements and IEC standards: Justification of the use for their inclusion in afterlaying test for extruded cable systems

Рік:

2016

Мова:

english

Файл:

PDF, 660 KB

english, 2016

Validity and Reliability of the 30-s Continuous Jump for Anaerobic Power and Capacity Assessment in Combat Sport

Čular, Drazen, Ivančev, Vladimir, Zagatto, Alessandro M., Milić, Mirjana, Beslija, Tea, Sellami, Maha, Padulo, Johnny

Журнал:

Frontiers in Physiology

Рік:

2018

Мова:

english

Файл:

PDF, 2.67 MB

english, 2018

176PClinical outcomes of delayed start of trastuzumab treatment in patients with early breast cancer: ml25232 study

Beslija, S., Ceric, T., Hasanbegovic, B., Kurtovic-Kozaric, A., Pasic, A., Mahic, N., Kalamujic, M., Cardzic, A., Alidzanovic, J., Marjanovic, I., Mekic-Abazovic, A.

Журнал:

The Journal of Strength and Conditioning Research

Рік:

2017

Мова:

english

Файл:

PDF, 50 KB

english, 2017

Reliability, Sensitivity, and Minimal Detectable Change of a New Specific Climbing Test for Assessing Asymmetry in Reach Technique

Čular, Dražen, Dhahbi, Wissem, Kolak, Ivo, Dello Iacono, Antonio, Bešlija, Tea, Laffaye, Guillaume, Padulo, Johnny

Журнал:

Рік:

2018

Мова:

english

Файл:

PDF, 290 KB

english, 2018

A clinicopathologic study of invasive apocrine carcinoma of the breast: A single-center experience

Imamovic, Denira, Bilalovic, Nurija, Skenderi, Faruk, Beslagic, Vanesa, Ceric, Timur, Hasanbegovic, Berisa, Beslija, Semir, Vranic, Semir

Журнал:

The Breast Journal

Рік:

2018

Мова:

english

Файл:

PDF, 367 KB

english, 2018

Explosive Push-ups

Zalleg, Dalenda, Ben Dhahbi, Anis, Dhahbi, Wissem, Sellami, Maha, Padulo, Johnny, Souaifi, Marouen, Bešlija, Tea, Chamari, Karim

Журнал:

The Journal of Strength and Conditioning Research

Рік:

2018

Мова:

english

Файл:

PDF, 303 KB

english, 2018

Clinicopathologic characteristics of invasive apocrine carcinoma of the breast: A single center experience from a country with limited resources

Imamovic, D., Bilalovic, N., Skenderi, F., Beslagic, V., Ceric, T., Hasanbegovic, B., Beslija, S., Vranic, S.

Журнал:

Рік:

2018

Мова:

english

Файл:

PDF, 47 KB

english, 2018

Clinicopathologic characteristics of invasive apocrine carcinoma of the breast: A single center experience from a country with limited resources

Imamovic, D., Bilalovic, N., Skenderi, F., Beslagic, V., Ceric, T., Hasanbegovic, B., Beslija, S., Vranic, S.

Журнал:

Рік:

2018

Файл:

PDF, 47 KB

2018

200PEffects of delayed initiation of adjuvant trastuzumab for non-metastatic, HER2 positive breast cancer in a limited resources setting: ML25232 study final results

Beslija, S, Ceric, T, Hasanbegovic, B, Skenderi, F, Alidžanović, J, Kopric, D, Marjanović, I, Mekic-Abazovic, A, Sisic, I S, Hammami, M, Pasic, A, Rasic, A, Kapisazović, E

Журнал:

Рік:

2019

Мова:

english

Файл:

PDF, 77 KB

english, 2019

409TiPPHASE III STUDY OF PALBOCICLIB IN COMBINATION WITH EXEMESTANE VS. CAPECITABINE, IN HORMONAL RECEPTOR (HR) POSITIVE/HER2 NEGATIVE METASTATIC BREAST CANCER (MBC) PATIENTS WITH RESISTANCE TO NON-STEROIDAL AROMATASE INHIBITORS (NSAI): PEARL STUDY (GEICAM/2013-02_CECOG/BC.1.3.006)

Martin, M., Beslija, S., Carrasco, E., Kahan, Z., Escudero, M.J., Láng, I., Bartlett, C.H., Bermejo, B., Inbar, M., Chacón, J.I., Jinga, D.C., García-Sáenz, J.A., Haba, J. De La, Koehler, M., Morales,

Журнал: